Back to Treatments

Treatment

Tumor Treating Fields (Optune)

1
Conditions
7
Trials
5,000
Participants
70%
Average Safety

Condition Evidence

Brain and central nervous system cancer

7 trials · 5,000 participants

65% effectiveness · 70% safety
Tumor Treating Fields (Optune) | DFDA